| Lindsey Stoltz Steadman, MD | |
|
46 Markfield Dr Ste A, Charleston, SC 29407-6982 | |
| (843) 556-7048 | |
| (843) 556-2938 |
| Full Name | Lindsey Stoltz Steadman |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 10 Years |
| Location | 46 Markfield Dr Ste A, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760896294 | NPI | - | NPPES |
| 370299 | Medicaid | SC | |
| SCF9145238 | Other | SC | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD37029 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy And Asthma Consultants, Llp | 6709880057 | 6 |
| Allergy Partners Pllc | 7113822420 | 149 |
News Archive
Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.
Celebrated writers such as Charles Dickens and George Eliot described characters' faces vividly without going into detail about their features, according to a research group led at the University of Strathclyde.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.
Changes in gene expression patterns in zebrafish embryos resulting from exposure to environmental toxins can identify the individual toxins at work, according to research published in the online open access journal Genome Biology.
With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.
› Verified 7 days ago
| Entity Name | Allergy Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538101258 PECOS PAC ID: 7113822420 Enrollment ID: O20050623000563 |
News Archive
Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.
Celebrated writers such as Charles Dickens and George Eliot described characters' faces vividly without going into detail about their features, according to a research group led at the University of Strathclyde.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.
Changes in gene expression patterns in zebrafish embryos resulting from exposure to environmental toxins can identify the individual toxins at work, according to research published in the online open access journal Genome Biology.
With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.
› Verified 7 days ago
| Entity Name | Allergy & Asthma Consultants, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528033263 PECOS PAC ID: 6709880057 Enrollment ID: O20060829000532 |
News Archive
Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.
Celebrated writers such as Charles Dickens and George Eliot described characters' faces vividly without going into detail about their features, according to a research group led at the University of Strathclyde.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.
Changes in gene expression patterns in zebrafish embryos resulting from exposure to environmental toxins can identify the individual toxins at work, according to research published in the online open access journal Genome Biology.
With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Stoltz Steadman, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Lindsey Stoltz Steadman, MD 46 Markfield Dr Ste A, Charleston, SC 29407-6982 Ph: (843) 556-7048 |
News Archive
Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.
Celebrated writers such as Charles Dickens and George Eliot described characters' faces vividly without going into detail about their features, according to a research group led at the University of Strathclyde.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from a fully enrolled and ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, ponatinib, in patients with resistant and refractory chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.
Changes in gene expression patterns in zebrafish embryos resulting from exposure to environmental toxins can identify the individual toxins at work, according to research published in the online open access journal Genome Biology.
With Medicaid spending growth almost doubling over the past year, a new document released today by Health and Human Services Secretary Kathleen Sebelius to all 50 governors encourages the use of lower-cost drugs - including generics - to help reduce Medicaid spending.
› Verified 7 days ago
Carolyn Reed Word, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 46 Markfield Dr Ste A, Charleston, SC 29407 Phone: 843-556-7048 Fax: 843-556-2938 | |
Haley Thompson, APRN Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 7555 Northside Dr, Charleston, SC 29420 Phone: 843-797-8162 Fax: 843-225-1270 | |
Andrew Evin Davidson, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 46 Markfield Dr Ste A, Charleston, SC 29407 Phone: 843-556-7048 Fax: 843-556-2938 | |
Thomas Bailey Harper Iii, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2270 Ashley Crossing Dr, Suite 150, Charleston, SC 29414 Phone: 843-556-9588 Fax: 843-556-6855 | |
Jeffrey James Dietrich, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 46 Markfield Dr Ste A, Charleston, SC 29407 Phone: 843-556-7048 Fax: 843-556-2938 | |
John Baldwin Cox, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Meredith L Moore, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 46 Markfield Dr Ste A, Charleston, SC 29407 Phone: 843-556-7048 Fax: 843-556-2938 |